About the journal

The Journal of Pharmaceutical and Biomedical Sciences (JPBS) is a peer-reviewed scientific journal focused on pharmaceutical formulation, drug delivery, pharmaceutical technology and biopharmaceutics, with particular emphasis on how these areas affect biological and therapeutic performance.

The journal therefore seeks to publish research that goes beyond the development or characterisation of a pharmaceutical formulation and demonstrates the impact of pharmaceutical design. Studies are of particular interest when they show how formulation and drug-delivery strategies influence drug stability, solubility, dissolution, permeability, bioavailability, targeting, pharmacokinetics, efficacy, safety or other clinically relevant properties.

JPBS covers both established and emerging approaches in the pharmaceutical sciences, including conventional and advanced dosage forms, controlled and targeted drug delivery, nanopharmaceuticals, pharmaceutical nanotechnology, natural-product formulations, biologics, pharmaceutical biotechnology, and other technologies that enhance the performance of therapeutic agents.

A defining feature of the journal is the link between pharmaceutical development and biological or therapeutic outcomes. Biological, pharmacological, microbiological, molecular or preclinical investigations are considered when they are directly relevant to the development, evaluation, mechanism or therapeutic performance of a pharmaceutical product or delivery system.

The journal particularly values research that follows a clear path: pharmaceutical design, then formulation or delivery, then biological performance, then therapeutic relevance. That emphasis distinguishes JPBS from journals that focus exclusively on formulation development or, conversely, on biomedical investigation that lacks a substantive pharmaceutical component.

JPBS welcomes original research articles, review articles, short communications and other scholarly contributions that provide rigorous, reproducible and meaningful advances in pharmaceutical science. The aim is a focused scientific forum for researchers seeking to transform pharmaceutical innovation into measurable improvements in drug performance and therapeutic application.

The journal is open access under a CC BY 4.0 licence. Peer review is double-anonymised. Volume, issue and article records are editor-managed; the public site does not invent identifiers, metrics or files.

Editorial focus

JPBS gives particular consideration to research that can clearly answer one or more of the following questions:

• Does the pharmaceutical design improve drug performance?
• Does the formulation or delivery system overcome a recognised pharmaceutical or biological barrier?
• Does the proposed approach improve efficacy, safety, stability, bioavailability, targeting or therapeutic selectivity?
• Is there experimental evidence connecting formulation characteristics with biological or therapeutic performance?
• Does the research provide a meaningful advance over existing pharmaceutical technologies or formulations?

Through this focused editorial approach, JPBS seeks to promote pharmaceutical research that moves from formulation design to functional performance and, ultimately, toward therapeutic impact.

The detailed aim, subject scope and out-of-scope boundary are published on Aims & scope. Author-facing instructions, including article types and publication ethics, live under For authors.

At a glance

Peer review

Double-anonymised

Access

Open access, CC BY 4.0

Publication

Continuous, with quarterly issues

Article types

Research, review, short communication, methods and related formats

Language

English

ISSN (Print)

2090-4290

ISSN (Online)

2090-4231

Licence

CC BY 4.0